Achievement of Control of Severe Bronchial Asthma When Using Dupilumab
The aim of the study was to evaluate the possibility of achieving control of severe bronchial asthma (BA) using genetically engineered biological therapy with Dupilumab. Materials and methods. The study included 32 patients with severe bronchial asthma (8 (25 %) men, mean age 58 [28; 65]) years, 2...
Saved in:
| Main Authors: | O. V. Kazmerchuk, E. A. Sobko, I. V. Demko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
SINAPS LLC
2024-11-01
|
| Series: | Архивъ внутренней медицины |
| Subjects: | |
| Online Access: | https://www.medarhive.ru/jour/article/view/1881 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern Understanding of Severe Bronchial Asthma
by: A. Yu. Kraposhina, et al.
Published: (2022-03-01) -
ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES
by: V. S. Krysanova, et al.
Published: (2021-08-01) -
Long-term outcomes of dupilumab therapy in severe asthma: A retrospective, multicenter, real-world study
by: Carlo Mümmler, MD, et al.
Published: (2025-11-01) -
Real world evidence of dupilumab effectiveness in a Colombian cohort of patients diagnosed with severe asthma
by: Abraham Alí-Munive, et al.
Published: (2025-05-01) -
Dupilumab efficacy in patients with type 2 asthma and early Feno level reductions
by: Ian D. Pavord, MD, et al.
Published: (2025-08-01)